Phase I-Ii Study of Clofarabine-Melphalan-Alemtuzumab Conditioning for Allogeneic Hematopoietic Cell Transplantation
Biology of Blood and Marrow Transplantation - Netherlands
doi 10.1016/j.bbmt.2011.10.041
Full Text
Open PDFAbstract
Available in full text
Date
June 1, 2012
Authors
Publisher
Elsevier BV